Lazard Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.9M | Buy |
22,637
+2,644
| +13% | +$490K | 0.01% | 636 |
|
|
2025
Q4 | $3.99M | Buy |
19,993
+12,388
| +163% | +$2.25M | 0.01% | 619 |
|
|
2025
Q3 | $1.19M | Buy |
7,605
+407
| +6% | +$64.6K | ﹤0.01% | 1084 |
|
|
2025
Q2 | $1.09M | Buy |
7,198
+2,952
| +70% | +$394K | ﹤0.01% | 1274 |
|
|
2025
Q1 | $639K | Sell |
4,246
-6,511
| -61% | -$1.09M | ﹤0.01% | 1344 |
|
|
2024
Q4 | $1.99M | Buy |
10,757
+3,194
| +42% | +$615K | ﹤0.01% | 883 |
|
|
2024
Q3 | $1.49M | Sell |
7,563
-27,487
| -78% | -$5.71M | ﹤0.01% | 951 |
|
|
2024
Q2 | $7.24M | Sell |
35,050
-30,184
| -46% | -$6.84M | 0.01% | 588 |
|
|
2024
Q1 | $17.7M | Buy |
65,234
+10,928
| +20% | +$2.61M | 0.02% | 411 |
|
|
2023
Q4 | $12.8M | Buy |
54,306
+2,269
| +4% | +$446K | 0.02% | 497 |
|
|
2023
Q3 | $10.2M | Buy |
52,037
+33,918
| +187% | +$6.96M | 0.01% | 557 |
|
|
2023
Q2 | $3.81M | Buy |
18,119
+2,855
| +19% | +$568K | ﹤0.01% | 763 |
|
|
2023
Q1 | $3.08M | Buy |
15,264
+500
| +3% | +$113K | ﹤0.01% | 828 |
|
|
2022
Q4 | $3.22M | Buy |
14,764
+722
| +5% | +$158K | ﹤0.01% | 808 |
|
|
2022
Q3 | $2.76M | Buy |
14,042
+3,991
| +40% | +$862K | ﹤0.01% | 818 |
|
|
2022
Q2 | $2.15M | Buy |
10,051
+10,047
| +251,175% | +$2.45M | ﹤0.01% | 889 |
|
|
2022
Q1 | $1K | Buy |
4
+2
| +100% | +$617 | ﹤0.01% | 2277 |
|
|
2021
Q4 | $0 | Sell |
2
-27,425
| -100% | -$10.7M | ﹤0.01% | 2311 |
|
|
2021
Q3 | $11.3M | Sell |
27,427
-100,626
| -79% | -$41.8M | 0.01% | 599 |
|
|
2021
Q2 | $47.4M | Sell |
128,053
-3,262
| -2% | -$1.09M | 0.05% | 290 |
|
|
2021
Q1 | $38.1M | Sell |
131,315
-25,313
| -16% | -$7.04M | 0.05% | 315 |
|
|
2020
Q4 | $39.1M | Sell |
156,628
-10,757
| -6% | -$2.56M | 0.05% | 307 |
|
|
2020
Q3 | $37.9M | Sell |
167,385
-39,585
| -19% | -$8.22M | 0.05% | 269 |
|
|
2020
Q2 | $36.1M | Buy |
206,970
+20,947
| +11% | +$3.34M | 0.06% | 237 |
|
|
2020
Q1 | $23.5M | Buy |
186,023
+5,694
| +3% | +$854K | 0.04% | 278 |
|
|
2019
Q4 | $27.5M | Buy |
180,329
+44,303
| +33% | +$6.13M | 0.04% | 294 |
|
|
2019
Q3 | $18M | Buy |
136,026
+90,419
| +198% | +$12.1M | 0.03% | 366 |
|
|
2019
Q2 | $6.47M | Buy |
45,607
+1,500
| +3% | +$203K | 0.01% | 541 |
|
|
2019
Q1 | $6.41M | Buy |
44,107
+40,157
| +1,017% | +$5.28M | 0.01% | 543 |
|
|
2018
Q4 | $447K | Buy |
3,950
+2,646
| +203% | +$331K | ﹤0.01% | 806 |
|
|
2018
Q3 | $175K | Buy |
+1,304
| New | +$161K | ﹤0.01% | 884 |
|
|
2016
Q1 | – | Sell |
-2,750
| Closed | -$221K | – | 1055 |
|
|
2015
Q4 | $221K | Buy |
2,750
+400
| +17% | +$28.8K | ﹤0.01% | 808 |
|
|
2015
Q3 | $149K | Sell |
2,350
-655
| -22% | -$47K | ﹤0.01% | 816 |
|
|
2015
Q2 | $211K | Buy |
+3,005
| New | +$222K | ﹤0.01% | 831 |
|
Other funds holding CRL
VCM
VPM
